Xaira Therapeutics, Inc.

Artificial intelligence was more than a buzzword in 2024; it shaped pharmaceutical industry investments throughout the year, with multiple billion-dollar partnerships and acquisitions across the drug

Biopharma financing during the fourth quarter of 2024 totaled $16.8bn from 251 deals. Of those, 60 reached $100m or more. The follow-on public offering (FOPO) and venture financing categories tied for

In Vivo’s editors, along with experts from the wider Citeline team, have selected our top four picks for the most significant M&A, alliance and financing deals of 2024. Vote now in the polls belo

The number of financings among life sciences companies in the TechBio sector increased from Q3 2023, stabilizing in H1 2024. During the period Q3 2023 – Q3 2024, a total of $6bn was raised, with the s